Helicobacter Pylori Eradication

INTERVENTION: The participants were randomised into two groups: Group 1: HP‐positive patients and HP‐positive partners were treated with levofloxacin 500 mg daily, amoxicillin 1g b.i.d and lansoprazole 30 mg b.i.d (LAL) for ten days. Group 2: Only the HP‐positive patients were treated with levofloxacin 500 mg daily, amoxicillin 1g b.i.d and lansoprazole 30 mg b.i.d (LAL) for ten days. CONDITION: Helicobacter pylori (HP) infection ; Infections and Infestations ; Helicobacter pylori PRIMARY OUTCOME: Eradication success rate SECONDARY OUTCOME: Re‐infection rate between partners INCLUSION CRITERIA: Helicobacter pylori positive patients and their partners